171 related articles for article (PubMed ID: 32805233)
61. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Mar; 30(9):1020-31. PubMed ID: 20972462
[TBL] [Abstract][Full Text] [Related]
62. Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.
Emmanuel C; Chiew YE; George J; Etemadmoghadam D; Anglesio MS; Sharma R; Russell P; Kennedy C; Fereday S; Hung J; Galletta L; Hogg R; Wain GV; Brand A; Balleine R; MacConaill L; Palescandolo E; Hunter SM; Campbell I; Dobrovic A; Wong SQ; Do H; Clarke CL; Harnett PR; Bowtell DD; deFazio A;
Clin Cancer Res; 2014 Dec; 20(24):6618-30. PubMed ID: 25316818
[TBL] [Abstract][Full Text] [Related]
63. The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.
Köbel M; Reuss A; du Bois A; Kommoss S; Kommoss F; Gao D; Kalloger SE; Huntsman DG; Gilks CB
J Pathol; 2010 Oct; 222(2):191-8. PubMed ID: 20629008
[TBL] [Abstract][Full Text] [Related]
64. Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma.
Berge G; Costea DE; Berg M; Rasmussen H; Grotterød I; Lothe RA; Mælandsmo GM; Flatmark K
Amino Acids; 2011 Oct; 41(4):875-84. PubMed ID: 20191297
[TBL] [Abstract][Full Text] [Related]
65. S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration.
Du M; Wang G; Ismail TM; Gross S; Fernig DG; Barraclough R; Rudland PS
J Biol Chem; 2012 May; 287(19):15330-44. PubMed ID: 22399300
[TBL] [Abstract][Full Text] [Related]
66. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.
Coaxum SD; Tiedeken J; Garrett-Mayer E; Myers J; Rosenzweig SA; Neskey DM
Oncotarget; 2017 Apr; 8(14):22991-23007. PubMed ID: 28160562
[TBL] [Abstract][Full Text] [Related]
67. Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.
Chen X; Zhang J; Zhang Z; Li H; Cheng W; Liu J
Hum Pathol; 2013 Nov; 44(11):2373-84. PubMed ID: 23850493
[TBL] [Abstract][Full Text] [Related]
68. Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting tumor growth.
Ishikawa M; Osaki M; Yamagishi M; Onuma K; Ito H; Okada F; Endo H
Oncogene; 2019 Jun; 38(24):4715-4728. PubMed ID: 30745574
[TBL] [Abstract][Full Text] [Related]
69. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
[TBL] [Abstract][Full Text] [Related]
70. Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.
Maelandsmo GM; Flørenes VA; Nguyen MT; Flatmark K; Davidson B
Tumour Biol; 2009; 30(1):15-25. PubMed ID: 19194111
[TBL] [Abstract][Full Text] [Related]
71. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
[TBL] [Abstract][Full Text] [Related]
72. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
73. [Role of S100A4 in the epithelial-mesenchymal transition of esophageal squamous cell carcinoma and its molecular mechanism].
Jian L; Zhihong W; Liuxing W; Qingxia F
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):258-65. PubMed ID: 26462889
[TBL] [Abstract][Full Text] [Related]
74. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
[TBL] [Abstract][Full Text] [Related]
75. Metastasis-associated protein S100A4: spotlight on its role in cell migration.
Tarabykina S; Griffiths TR; Tulchinsky E; Mellon JK; Bronstein IB; Kriajevska M
Curr Cancer Drug Targets; 2007 May; 7(3):217-28. PubMed ID: 17504119
[TBL] [Abstract][Full Text] [Related]
76. Phenothiazines inhibit S100A4 function by inducing protein oligomerization.
Malashkevich VN; Dulyaninova NG; Ramagopal UA; Liriano MA; Varney KM; Knight D; Brenowitz M; Weber DJ; Almo SC; Bresnick AR
Proc Natl Acad Sci U S A; 2010 May; 107(19):8605-10. PubMed ID: 20421509
[TBL] [Abstract][Full Text] [Related]
77. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
78. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
[TBL] [Abstract][Full Text] [Related]
79. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
[TBL] [Abstract][Full Text] [Related]
80. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
Pon YL; Zhou HY; Cheung AN; Ngan HY; Wong AS
Cancer Res; 2008 Aug; 68(16):6524-32. PubMed ID: 18701475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
